Physical therapy in Parkinson’s disease: an open long-term rehabilitation trial

被引:0
|
作者
M. T. Pellecchia
A. Grasso
L. G. Biancardi
M. Squillante
V. Bonavita
P. Barone
机构
[1] University “Federico II”,Department of Neurological Sciences
来源
Journal of Neurology | 2004年 / 251卷
关键词
Parkinson’s disease; long-term rehabilitation; UPDRS; depression;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to evaluate the effects of prolonged physical therapy on disability in patients with Parkinson’s disease. The study was designed as an open long-term trial over 20 weeks. Twenty slightly to moderately affected parkinsonian patients were included (Hoehn & Yahr stages: 1.5–3). A comprehensive rehabilitation program was applied three times a week in all patients. Pharmacological treatment was kept stable. Evaluations were performed at baseline, at the end of treatment and after 3 months. Following physical rehabilitation, there was a significant improvement in UPDRS (ADL and motor sections) scores, Self-assessment Parkinson’s disease Disability Scale, Ten-Meter Walk test and Zung scale for depression. At 3-month follow-up clinical improvements were largely maintained. A sustained improvement of motor skills in PD patients can be achieved with a long-term comprehensive rehabilitation program.
引用
收藏
页码:595 / 598
页数:3
相关论文
共 50 条
  • [31] Long-Term Antidyskinetic Efficacy of Amantadine in Parkinson's Disease
    Wolf, Elisabeth
    Seppi, Klaus
    Katzenschlager, Regina
    Hochschorner, Guenter
    Ransmayr, Gerhard
    Schwingenschuh, Petra
    Ott, Erwin
    Kloiber, Iris
    Haubenberger, Dietrich
    Auff, Eduard
    Poewe, Werner
    MOVEMENT DISORDERS, 2010, 25 (10) : 1357 - 1363
  • [32] Long-Term Treatment of Advanced Parkinson's Disease with Rotigotine
    LeWitt, Peter A.
    Boroojerdi, Babak
    Poewe, Werner
    NEUROLOGY, 2010, 74 (09) : A350 - A350
  • [33] Parkinson's disease - New outlook on long-term treatment
    Weber, R
    NERVENHEILKUNDE, 1995, 14 (07) : 80 - 81
  • [34] Long-Term Efficacy of Rasagiline in Early Parkinson's Disease
    Lew, Mark F.
    Hauser, Robert A.
    Hurtig, Howard I.
    Ondo, William G.
    Wojcieszek, Joanne
    Goren, Tamar
    Fitzer-Attas, Cheryl J.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2010, 120 (06) : 404 - 408
  • [35] Long-term treatment of advanced Parkinson's disease with rotigotine
    LeWitt, P. A.
    Boroojerdi, B.
    Poewe, W.
    MOVEMENT DISORDERS, 2010, 25 (07) : S299 - S300
  • [36] Long-term effect of unilateral subthalamotomy for Parkinson's disease
    Ricardo, Yordanka
    Pavon, Nancy
    Alvarez, Lazaro
    Casabona, Enrique
    Teijeiro, Juan
    Diaz, Amado
    Maragoto, Carlos
    Pedroso, Ivon
    Garcia-Maeso, Ivan
    Uriel Manez-Miro, Jorge
    Martinez-Fernandez, Raul
    Macias, Raul
    Jose Angel, Obeso
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : 1380 - +
  • [37] Long-Term Statin Use and the Risk of Parkinson's Disease
    Friedman, Bitya
    Lahad, Amnon
    Dresner, Yizchak
    Vinker, Shlomo
    AMERICAN JOURNAL OF MANAGED CARE, 2013, 19 (08): : 626 - 632
  • [38] Long-term efficacy of rasagiline in Parkinson's disease patients
    Lew, M. F.
    Hauser, R.
    Hurtig, H. I.
    Ondo, W.
    Wojcieszek, J. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 16 - 16
  • [39] Long-Term Outcomes of Surgical Therapies for Parkinson's Disease
    Rodriguez-Oroz, Maria C.
    Moro, Elena
    Krack, Paul
    MOVEMENT DISORDERS, 2012, 27 (14) : 1718 - 1728
  • [40] Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
    Mittermeyer, Gabriele
    Christine, Chadwick W.
    Rosenbluth, Kathryn H.
    Baker, Suzanne L.
    Starr, Philip
    Larson, Paul
    Kaplan, Paul L.
    Forsayeth, John
    Aminoff, Michael J.
    Bankiewicz, Krystof S.
    HUMAN GENE THERAPY, 2012, 23 (04) : 377 - 381